GeneDx Holdings Corp. (WGS) Earnings History
Annual and quarterly earnings data from 2020 to 2025
Loading earnings history...
WGS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
WGS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 69.7% | -2.8% | -4.9% |
| 2024 | 63.6% | -7.6% | -17.1% |
| 2023 | 44.4% | -89.2% | -86.8% |
| 2022 | -11.4% | -284.5% | -233.9% |
| 2021 | -7.8% | -210.3% | -115.6% |
Download Data
Export WGS earnings history in CSV or JSON format
Free sign-in required to download data
GeneDx Holdings Corp. (WGS) Earnings Overview
As of May 8, 2026, GeneDx Holdings Corp. (WGS) reported trailing twelve-month net income of -$78M, reflecting +62.4% year-over-year growth. The company earned $-2.65 per diluted share over the past four quarters, with a net profit margin of -4.9%.
Looking at the long-term picture, WGS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$21M in fiscal 2025, representing a new all-time high.
GeneDx Holdings Corp. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PACB (-$546M net income, -341.5% margin), NTRA (-$208M net income, -9.0% margin), EXAS (-$208M net income, -6.4% margin), WGS has outperformed on profitability metrics. Compare WGS vs PACB →
WGS Earnings vs Peers
Earnings metrics vs comparable public companies
WGS Historical Earnings Data (2020–2025)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$21M | +59.8% | -$12M | $-0.73 | -4.9% | -2.8% |
| 2024 | -$52M | +70.3% | -$23M | $-1.94 | -17.1% | -7.6% |
| 2023 | -$176M | +68.0% | -$181M | $-7.23 | -86.8% | -89.2% |
| 2022 | -$549M | -123.7% | -$668M | $-53.63 | -233.9% | -284.5% |
| 2021 | -$245M | -1.7% | -$446M | $-74.93 | -115.6% | -210.3% |
| 2020 | -$241M | - | -$242M | $-146.94 | -134.6% | -134.9% |
See WGS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs WGS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare WGS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonWGS — Frequently Asked Questions
Quick answers to the most common questions about buying WGS stock.
Is WGS growing earnings?
WGS EPS is $-2.65, with earnings growth accelerating to +62.4%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-78M.
What are WGS's profit margins?
GeneDx Holdings Corp. net margin is -4.9%, with operating margin at -2.8%. Below-average margins reflect competitive or cost pressures.
How consistent are WGS's earnings?
WGS earnings data spans 2020-2025. The accelerating earnings trend is +62.4% YoY. Historical data enables comparison across business cycles.